A poll found the vast majority of adults support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans.
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
This article is for premium subscribers. Please sign up here for a tax-deductible subscription.
If you're a premium subscriber, sign in below.
An Oregon program that aims to peel back the opaque layers of prescription drug pricing wrapped up its first year this week with a report to the Legislature that underlines
While prescription costs continue rising faster than other healthcare expenses, some in the research industry contend that since drugs comprise a smaller portion of the overall cost, their impact has been overstated.
